{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":30,"n_cols":5,"rows_kept":30,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[24,2,24,3],[25,2,25,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910153340703321"]
[null,null,"Autore",null,"Elisabeth Chamorand"]
[null,null,"Titolo",null,"L'accès aux médicaments dans les pays en développement - De 2001 (Déclaration de Doha) à 2013"]
[null,null,"Pubbl/distr/stampa",null,"Paris"]
[{"$nulls":4},"Editions L'Harmattan"]
[{"$nulls":4},"2013"]
[null,null,"ISBN",null,"2-336-67270-7"]
[null,null,"Descrizione fisica",null,"1 online resource (118 p.)"]
[null,null,"Soggetti",null,"Drug accessibility - History - 21st century - Developing countries"]
[{"$nulls":4},"Pharmaceutical industry - History - 21st century - Developing countries"]
[{"$nulls":4},"Pharmaceutical policy - History - 21st century - Developing countries"]
[{"$nulls":4},"Public health - History - 21st century - Developing countries"]
[{"$nulls":4},"Pharmaceutical Preparations"]
[{"$nulls":4},"International Cooperation"]
[{"$nulls":4},"History, Modern 1601-"]
[{"$nulls":4},"Internationality"]
[{"$nulls":4},"History"]
[{"$nulls":4},"Chemicals and Drugs"]
[{"$nulls":4},"Humanities"]
[{"$nulls":4},"Social Sciences"]
[{"$nulls":4},"Anthropology, Education, Sociology and Social Phenomena"]
[{"$nulls":4},"Drugs, Essential"]
[{"$nulls":4},"History, 21st Century"]
[{"$nulls":4},"Developing Countries"]
[null,null,"Lingua di pubblicazione",null,"Francese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Elisabeth Chamorand"]
[null,null,null,"Sommario/riassunto","Ce livre tente de présenter les différentes facettes de la politique commerciale des Etats-Unis, de l'Europe et de la Suisse, qui ont systématiquement cherché à entraver la production et l'exportation de médicaments génériques de qualité afin d'assurer des bénéfices élevés à leurs entreprises pharmaceutiques et de retracer dix ans de débats "]
[{"$nulls":4},"infructueux à l'OMS pour faciliter l'accès à des médicaments innovants, appropriés, d'un coût abordable, aux pays à revenus faibles."]